<VariationArchive VariationID="430502" VariationName="NM_000093.5(COL5A1):c.4697dup (p.Glu1571fs)" VariationType="Duplication" Accession="VCV000430502" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2017-07-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="421724" VariationID="430502">
      <GeneList>
        <Gene Symbol="COL5A1" FullName="collagen type V alpha 1 chain" GeneID="1289" HGNC_ID="HGNC:2209" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="134641803" stop="134844843" display_start="134641803" display_stop="134844843" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="137533651" stop="137736688" display_start="137533651" display_stop="137736688" Strand="+" />
          </Location>
          <OMIM>120215</OMIM>
          <Haploinsufficiency last_evaluated="2017-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL5A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL5A1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC101448202" FullName="uncharacterized LOC101448202" GeneID="101448202" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="134819415" stop="134872618" display_start="134819415" display_stop="134872618" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000093.5(COL5A1):c.4697dup (p.Glu1571fs)</Name>
      <CanonicalSPDI>NC_000009.12:134823462:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="134823462" stop="134823463" display_start="134823462" display_stop="134823463" variantLength="1" positionVCF="134823462" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="137715308" stop="137715309" display_start="137715308" display_stop="137715309" variantLength="1" positionVCF="137715308" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>E1571fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278074.1" sequenceAccession="NM_001278074" sequenceVersion="1" change="c.4697dup">
            <Expression>NM_001278074.1:c.4697dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265003.1" sequenceAccession="NP_001265003" sequenceVersion="1" change="p.Glu1571fs">
            <Expression>NP_001265003.1:p.Glu1571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.137715314dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.137715314dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.134823468dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.134823468dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008030.1" sequenceAccession="NG_008030" sequenceVersion="1" change="g.186663dup">
            <Expression>NG_008030.1:g.186663dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000093.5" sequenceAccession="NM_000093" sequenceVersion="5" change="c.4697dup" MANESelect="true">
            <Expression>NM_000093.5:c.4697dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000084.3" sequenceAccession="NP_000084" sequenceVersion="3" change="p.Glu1571fs">
            <Expression>NP_000084.3:p.Glu1571fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_737" sequenceAccession="LRG_737">
            <Expression>LRG_737:g.186663dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_737t2" sequenceAccession="LRG_737t2">
            <Expression>LRG_737t2:c.4697dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_737p2" sequenceAccession="LRG_737p2" change="p.Glu1571fs">
            <Expression>LRG_737p2:p.Glu1571fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_737t1" sequenceAccession="LRG_737t1">
            <Expression>LRG_737t1:c.4697dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645369417" DB="ClinGen" />
        <XRef Type="rs" ID="1131691996" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000093.5(COL5A1):c.4697dup (p.Glu1571fs) AND not provided" Accession="RCV000494192" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000093.5(COL5A1):c.4697dup (p.Glu1571fs) AND Ehlers-Danlos syndrome" Accession="RCV002279271" Version="3">
        <ClassifiedConditionList TraitSetID="11842">
          <ClassifiedCondition DB="MedGen" ID="C0013720">Ehlers-Danlos syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000093.5(COL5A1):c.4697dup (p.Glu1571fs) AND Ehlers-Danlos syndrome, classic type, 1" Accession="RCV002527112" Version="2">
        <ClassifiedConditionList TraitSetID="56939">
          <ClassifiedCondition DB="MedGen" ID="C0268335">Ehlers-Danlos syndrome, classic type, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-13" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-07-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16431952</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23587214</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11842" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ED syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome</ElementValue>
                <XRef ID="MONDO:0020066" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS130000" DB="OMIM" />
                <XRef ID="398114001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6322" />
                <XRef ID="6322" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CSANZ, 2017">
                <ID Source="PubMed">28161018</ID>
              </Citation>
              <XRef ID="98249" DB="Orphanet" />
              <XRef ID="C0013720" DB="MedGen" />
              <XRef ID="MONDO:0020066" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS130000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="56939" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="54525" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, classic type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS I</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, GRAVIS TYPE</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, SEVERE CLASSIC TYPE</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, classic type, 1</ElementValue>
                <XRef ID="MONDO:0019567" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, type 1</ElementValue>
                <XRef ID="Ehlers-Danlos+Syndrome+Classic+Type/2484" DB="Genetic Alliance" />
                <XRef ID="83470009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS1</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EDSCL1</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">cEDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.</Attribute>
                <XRef ID="NBK1244" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301422</ID>
                <ID Source="BookShelf">NBK1244</ID>
              </Citation>
              <XRef ID="C0268335" DB="MedGen" />
              <XRef ID="MONDO:0019567" DB="MONDO" />
              <XRef Type="MIM" ID="130000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1135079" SubmissionDate="2019-01-29" DateLastUpdated="2017-07-02" DateCreated="2017-07-02">
        <ClinVarSubmissionID localKey="GDX:701393|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000583321" DateUpdated="2017-07-02" DateCreated="2017-07-02" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.4697dupC pathogenic variant in the COL5A1 gene has been reported in association with cEDS; however, detailed clinical information and segregation data were not provided (Segev et al., 2006). This variant has not been observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.4697dupC variant causes a shift in reading frame starting at codon glutamic acid 1571, changing it to an arginine, and creating a premature stop codon at position 53 of the new reading frame, denoted p.Glu1571ArgfsX53. This pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift and nonsense variants in the COL5A1 gene have been reported in Human Gene Mutation Database in association with EDS (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL5A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="CC" referenceAllele="C" start="137715314" stop="137715315" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000093.3:c.4697dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5016221" SubmissionDate="2022-08-23" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="2022-05297|MONDO:0020066" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002565763" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL5A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000093.4:c.4697dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0020066" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11963989</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6129555" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4883749|MedGen:C0268335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003441510" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23587214</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16431952</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu1571Argfs*53) in the COL5A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL5A1 are known to be pathogenic (PMID: 23587214). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Ehlers-Danlos syndrome (PMID: 16431952). It has also been observed to segregate with disease in related individuals. This variant is also known as 4692-4693 ins C. ClinVar contains an entry for this variant (Variation ID: 430502). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL5A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.137715308_137715309insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5016221" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0020066" MappingRef="MONDO">
        <MedGen CUI="C0013720" Name="Ehlers-Danlos syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1135079" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6129555" TraitType="Disease" MappingType="XRef" MappingValue="C0268335" MappingRef="MedGen">
        <MedGen CUI="C0268335" Name="Ehlers-Danlos syndrome, classic type, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

